The rise of Sildenafil initially sparked a period of growth for the drug industry, nevertheless recent changes present a uncertain outlook for shareholders. Generic alternatives are reducing revenue, and ongoing patent https://safiyaubzh567407.vidublog.com/39884226/the-blue-pill-and-the-pharmaceutical-industry-a-precarious-investment